Body Revival, Health Reactive is the first ayurvedic product to be tested on cancer survivors in clinical trials.

The clinical trials were conducted following the guidelines of ICMR-CTRI. The trial was conducted under careful guidelines and headed by an experienced team of Oncologists from J.B. Roy State Ayurvedic and Medical College, Kolkata. The trial was conducted for a duration of 11 months, from 1st October 2023 to 30th November 2024. These trials are officially registered with the Clinical Trials Registry of India (CTRI-ICMR), under CTRI/2023/11/059465.

Clinical Trial Findings of Body Revival

• Enhanced Quality of Life (QoL): Body Revival® significantly improved physical and psychological well-being in breast cancer patients.
• Improved Performance Status: Patients reported enhanced daily functionality and energy levels.
• Reduction in Side Effects: Patients experienced fewer chemotherapy and radiation-related side effects.
• Enhanced Physical Health: Increased appetite, stamina, and endurance, coupled with reductions in nausea, constipation, muscle weakness, dizziness, and fatigue.
• Liver and Blood Benefits: Marked decreased liver enzyme levels and improved blood protein and haemoglobin counts.

The trial highlighted that “In-silico HER-2 receptor binding affinity with Symconoside B similar to Tamoxifen.“

Tamoxifen is a widely used drug in the treatment of hormone receptor-positive breast cancer. It works by blocking the estrogen receptor, preventing cancer growth.This suggests that Body Revival may support traditional cancer treatments and enhance therapeutic efficacy in hormone-sensitive cancers.

Why this matters

This clinical trial isn’t just about one product or one company—it’s about showing the world what Ayurveda can do. By successfully completing clinical trials, we’ve proven that Ayurvedic products can meet the highest standards of scientific research and make a meaningful difference in people’s lives.